Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India
· Delayed Price · Currency is INR 110.40
+3.41 (3.19%)
Mar 10, 2026, 12:57 PM IST
Bafna Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,531 | 1,769 | 1,853 | 1,940 | 2,996 | 3,252 | Upgrade
|
| Market Cap Growth | 36.14% | -4.53% | -4.45% | -35.25% | -7.86% | 10234.58% | Upgrade
|
| Enterprise Value | 2,852 | 1,945 | 1,941 | 2,104 | 3,042 | 3,275 | Upgrade
|
| Last Close Price | 106.99 | 74.80 | 78.35 | 82.00 | 126.65 | 137.45 | Upgrade
|
| PE Ratio | 26.18 | 42.61 | 25.23 | 17.11 | 57.44 | 55.81 | Upgrade
|
| PS Ratio | 1.72 | 1.21 | 1.22 | 1.68 | 3.52 | 4.57 | Upgrade
|
| PB Ratio | 2.77 | 2.09 | 2.29 | 2.64 | 4.84 | 5.73 | Upgrade
|
| P/TBV Ratio | 2.77 | 2.09 | 2.34 | 2.70 | 4.84 | 5.73 | Upgrade
|
| P/FCF Ratio | - | 640.66 | - | - | 136.99 | - | Upgrade
|
| P/OCF Ratio | - | 7.99 | 19.54 | 39.17 | 30.80 | - | Upgrade
|
| EV/Sales Ratio | 1.93 | 1.33 | 1.27 | 1.82 | 3.57 | 4.60 | Upgrade
|
| EV/EBITDA Ratio | 17.60 | 16.63 | 16.94 | 12.30 | 25.07 | 30.83 | Upgrade
|
| EV/EBIT Ratio | 25.03 | 28.59 | 30.03 | 17.88 | 45.81 | 53.29 | Upgrade
|
| EV/FCF Ratio | - | 704.05 | - | - | 139.09 | - | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.33 | 0.30 | 0.31 | 0.18 | 0.28 | Upgrade
|
| Debt / EBITDA Ratio | 2.00 | 2.41 | 2.13 | 1.34 | 0.91 | 1.49 | Upgrade
|
| Debt / FCF Ratio | - | 102.10 | - | - | 5.06 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.35 | 0.29 | 0.28 | 0.21 | 0.18 | 0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.98 | 2.12 | 2.01 | 0.88 | 0.90 | 1.32 | Upgrade
|
| Net Debt / FCF Ratio | - | 89.67 | -3.77 | -8.56 | 4.98 | -0.71 | Upgrade
|
| Asset Turnover | - | 0.97 | 1.10 | 1.05 | 0.96 | 0.90 | Upgrade
|
| Inventory Turnover | - | 3.58 | 4.14 | 3.62 | 2.89 | 3.39 | Upgrade
|
| Quick Ratio | - | 0.84 | 0.87 | 1.05 | 0.68 | 0.92 | Upgrade
|
| Current Ratio | - | 1.66 | 1.73 | 1.88 | 2.31 | 2.04 | Upgrade
|
| Return on Equity (ROE) | - | 5.01% | 9.53% | 16.74% | 8.79% | 10.82% | Upgrade
|
| Return on Assets (ROA) | - | 2.83% | 2.91% | 6.70% | 4.70% | 4.88% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.24% | 6.37% | 6.72% | 14.24% | 9.25% | 10.57% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 6.70% | 6.90% | 14.20% | 9.70% | 9.90% | Upgrade
|
| Earnings Yield | 3.82% | 2.35% | 3.96% | 5.85% | 1.74% | 1.79% | Upgrade
|
| FCF Yield | - | 0.16% | -3.29% | -0.91% | 0.73% | -6.06% | Upgrade
|
| Buyback Yield / Dilution | 0.14% | - | - | - | 0.13% | -901.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.